Centene (CNC) to Announce Quarterly Earnings on Tuesday

Centene (NYSE:CNCGet Free Report) is expected to announce its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect Centene to post earnings of $1.08 per share and revenue of $47.6405 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 8:30 AM ET.

Centene (NYSE:CNCGet Free Report) last posted its earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share for the quarter, beating the consensus estimate of $2.23 by $1.14. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The firm had revenue of $49.94 billion during the quarter, compared to analyst estimates of $47.53 billion. During the same period in the previous year, the firm earned $2.90 EPS. The business’s quarterly revenue was up 7.1% on a year-over-year basis. On average, analysts expect Centene to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Centene Stock Performance

CNC opened at $63.35 on Friday. The firm has a fifty day moving average price of $63.46 and a 200 day moving average price of $49.69. Centene has a 1 year low of $25.08 and a 1 year high of $69.36. The stock has a market cap of $31.28 billion, a P/E ratio of -4.82, a P/E/G ratio of 0.50 and a beta of 1.07. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.12 and a quick ratio of 1.12.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CNC. UBS Group restated a “neutral” rating and issued a $61.00 price objective (up from $55.00) on shares of Centene in a report on Friday, May 22nd. Sanford C. Bernstein increased their target price on shares of Centene from $48.00 to $68.00 and gave the company an “outperform” rating in a research report on Tuesday, May 5th. Royal Bank Of Canada raised their price target on shares of Centene from $70.00 to $71.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Zacks Research lowered shares of Centene from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 29th. Finally, Cantor Fitzgerald upped their price objective on shares of Centene from $60.00 to $75.00 and gave the company an “overweight” rating in a research note on Tuesday, July 7th. Seven research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $64.61.

Get Our Latest Research Report on CNC

Institutional Trading of Centene

Hedge funds have recently added to or reduced their stakes in the company. DV Equities LLC acquired a new position in Centene during the 4th quarter worth approximately $26,000. IFC & Insurance Marketing Inc. acquired a new stake in shares of Centene in the 4th quarter valued at $28,000. McMillan Office Inc. purchased a new stake in shares of Centene during the 4th quarter worth $49,000. MUFG Securities EMEA plc acquired a new position in shares of Centene during the second quarter worth $79,000. Finally, Intesa Sanpaolo Wealth Management purchased a new position in Centene in the fourth quarter valued at $60,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

About Centene

(Get Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Featured Articles

Earnings History for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.